N''-cyano-N-(2-methoxyphenyl)guanidine | 75564-72-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N''-cyano-N-(2-methoxyphenyl)guanidine
• 英文别名: N"-cyano-N-(2-methoxyphenyl)guanidine
• CAS: 75564-72-6
• 化学式: C₉H₁₀N₄O
• 分子量: 190.2
• InChiKey: IQYUIARKXKFWLV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  83.4
• 氢给体数：
  2
• 氢受体数：
  3

文献信息

• Potassium channel openers
  申请人：Abbott Laboratories

  公开号：US06645968B2

  公开（公告）日：2003-11-11

  Compounds of formula I: are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.

  公式I的化合物： 在预防或用钾通道开放剂改善的疾病治疗中有用。还公开了钾通道开放组合物和一种在哺乳动物中开放钾通道的方法。
• The Synthesis of 3,5-Diamino-1,2,4-oxadiazoles. 2nd Communication
  作者：Jefferson W. Tilley、Henri Ramuz、Paul Levitan、John F. Blount

  DOI：10.1002/hlca.19800630412

  日期：1980.6.6

  The 5-amino-3-arylamino-1,2,4-oxadiazoles 2 are conveniently prepared by oxidative cyclization of the arylamidinoureas 10. The process is also capable of producing a variety of the 5-substituted-amino analogs 32 when the appropriately substituted guanidine 31 is employed as the substrate. Two different types of rearrangement leading to triazol-3-ones accompany cyclization depending on the choice of

  通过氨基芳基尿素10的氧化环化，可以方便地制备5-氨基-3-芳基氨基-1,2,4-恶二唑2。当使用适当取代的胍31作为底物时，该方法还能够产生多种5-取代的氨基类似物32。取决于原料的选择，导致三唑-3-酮的两种不同类型的重排伴随环化。通过X射线晶体学分析确定了重排产物的结构，并讨论了导致这些意外产物的反应机理。
• Repurposing N,N'-bis-(arylamidino)-1,4-piperazinedicarboxamidines: An unexpected class of potent inhibitors of cholinesterases
  作者：Anne Loesche、Jana Wiese、Sven Sommerwerk、Vivienne Simon、Wolfgang Brandt、René Csuk

  DOI：10.1016/j.ejmech.2016.09.051

  日期：2017.1

  therapeutics and to reduce the time-to-market time-span. Following this concept a small library of compounds was screened for their ability to act as inhibitors of acetyl- and butyrylcholinesterase. Picloxydine, an established antiseptic, was shown to be an inhibitor for both enzymes. Systematic variation of the aryl substituents led to analogs possessing almost the same good properties as gold standard galantamine

  重新调整药物用途（=重新放置药物）是一种有效的方法，可以降低开发新疗法的成本并缩短上市时间。根据这个概念，筛选了小的化合物文库作为乙酰基和丁酰胆碱酯酶抑制剂的能力。已证明的吡氯西丁是一种杀菌剂，是两种酶的抑制剂。芳基取代基的系统变化导致类似物具有与金标准加兰他敏氢溴酸盐几乎相同的良好性能。
• Discovery and Biological Evaluation of Novel Cyanoguanidine P2X₇ Antagonists with Analgesic Activity in a Rat Model of Neuropathic Pain
  作者：Arturo Perez-Medrano、Diana L. Donnelly-Roberts、Prisca Honore、Gin C. Hsieh、Marian T. Namovic、Sridhar Peddi、Qi Shuai、Ying Wang、Connie R. Faltynek、Michael F. Jarvis、William A. Carroll

  DOI：10.1021/jm8015848

  日期：2009.5.28

  We disclose the design of a novel series of cyanoguanidines that are potent (IC50 similar or equal to 10-100 nM) and selective (>= 100-fold) P2X(7) receptor antagonists against the other P2 receptor subtypes such as the P2Y(2), P2X(4), and P2X(3). We also found that these P2X(7) antagonists effectively reduced nociception in a rat model of neuropathic pain (Chung model). Particularly, analogue 53 proved to be effective in the Chung model, with an ED50 of 38 mu mol/kg after intraperitoneal administration. In addition compound 53 exhibited antiallodynic effects following oral administration and maintained its efficacy following repeated administration in the Chung model. These results suggest an important role of P2X(7) receptors in neuropathic pain and therefore a potential use of P2X(7) antagonists as novel therapeutic tools for the treatment of this type of pain.
• TILLEY J. W.; RAMUZ H.; LEVITAN P.; BLOUNT J. F., HELV. CHIM. ACTA, 1980, 63, NO 4, 841-854
  作者：TILLEY J. W.、 RAMUZ H.、 LEVITAN P.、 BLOUNT J. F.

  DOI：——

  日期：——